---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-156438"
form_type: "8-K"
ticker: "OSCR"
cik: "0001568651"
company_name: "Oscar Health, Inc."
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:34:11.297555+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "medium"
source: SEC EDGAR
---

# Oscar Health reconfirms FY2024 guidance, to provide updated strategic targets at Investor Day

## Summary
- Reaffirms full-year 2024 guidance as provided in Q4 2023 earnings release dated Feb 7, 2024.
- Will update on Adjusted EBITDA performance through April 30, 2024.
- To discuss long-term growth targets and strategic levers at June 7 Investor Day.

## SEC filing metadata
- accession: 0001193125-24-156438
- form_type: 8-K
- ticker: OSCR
- cik: 0001568651
- company_name: Oscar Health, Inc.
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: medium
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1568651/000119312524156438/0001193125-24-156438-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1568651/000119312524156438/d847750d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-156438
- JSON: https://secwatch.observer/filing/0001193125-24-156438.json
- Plain text: https://secwatch.observer/filing/0001193125-24-156438.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.